The Lynx Group

Bringing the Patient into the Conversation



Patients should be given information about the benefits and the consequences, the outcomes of the therapies they’re being offered.

Yes, maybe there is a situation where costs can feature in that, given that some of these therapies are end of life, and the benefits may be marginal and the costs may be high.

Related Articles

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: